Fisher & Paykel Healthcare Surpasses $2 Billion Revenue Milestone

Fisher & Paykel Healthcare Corporation Limited ( (FSPKF) ) has released its Q4 earnings. Here is a breakdown of the information Fisher & Paykel Healthcare Corporation Limited presented to its investors.

Fisher & Paykel Healthcare Corporation Limited is a leading company in the design, manufacture, and marketing of products and systems for respiratory care, surgery, and the treatment of obstructive sleep apnea, with a strong presence in over 120 countries worldwide. The company recently announced its 2025 financial year results, marking a significant milestone by surpassing $2 billion in annual revenue for the first time. Key financial highlights include a 16% increase in operating revenue to $2.02 billion and a 43% rise in net profit after tax to $377.2 million. The Hospital product group saw an 18% revenue increase, while the Homecare product group achieved a 13% rise. The company also invested $226.9 million in research and development to drive innovation. Looking forward, Fisher & Paykel Healthcare remains committed to sustainable, profitable growth, focusing on improving patient care and expanding its global reach.